00:00The rivalry between Novo Nordisk and Eli Lilly has escalated into a courtroom showdown,
00:06with Novo accusing its competitor of misleading consumers through advertising for blockbuster
00:11GLP-1 drugs. The lawsuit claims Lilly compared its highest dose medications against older,
00:18lower dose versions of Novo's treatments, creating an unfair advantage in marketing materials.
00:24Novo is asking the court to pull the ads, require corrective messaging, and award damages,
00:29as the fight for dominance in the booming weight loss drug market intensifies.
00:34The case could reshape how pharmaceutical companies market one of the world's fastest-growing classes of medicines.
Comments